Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/201830/09/2022

Collaborative partners

Funding

  • Wellcome Trust: £165,313.81